MP
Maitry Patel
About Maitry Patel
Data last updated:
Maitry Patel is a Director at Brayton Pharmaceuticals Private Limited (since 2026). The company operates in Healthcare. Brayton Pharmaceuticals Private Limited reported revenue of ₹8.01 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Brayton Pharmaceuticals Private Limited U24239GJ2012PTC070037 | Director | 03 Feb 2026 | ₹8.01 Cr (FY 2025) | Active |
Board colleagues of Maitry Patel
| Name | DIN | Company | Designation |
|---|---|---|---|
| Darshak Bharatkumar Patel | 05236375 | Brayton Pharmaceuticals Private Limited | Director |
| Darshana Darshak Patel | 07467278 | Brayton Pharmaceuticals Private Limited | Director |
| Himanshu Patel | 11502201 | Brayton Pharmaceuticals Private Limited | Director |
| Sagar Anilkumar Patel | 08395717 | Brayton Pharmaceuticals Private Limited | Director |
| Vishrut Dineshkumar Shah | 10273020 | Brayton Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Maitry Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maitry Patel
Maitry Patel currently holds 1 directorship: Brayton Pharmaceuticals Private Limited (Director, since 03 Feb 2026, revenue ₹8.01 Cr (FY 2025)).
Maitry Patel was first appointed on 03 Feb 2026 as Director at Brayton Pharmaceuticals Private Limited.
The current boards of Maitry Patel's companies include Darshak Bharatkumar Patel (Brayton Pharmaceuticals Private Limited), Darshana Darshak Patel (Brayton Pharmaceuticals Private Limited), Himanshu Patel (Brayton Pharmaceuticals Private Limited), Sagar Anilkumar Patel (Brayton Pharmaceuticals Private Limited), Vishrut Dineshkumar Shah (Brayton Pharmaceuticals Private Limited).